Acetylcholinesterase Inhibitors: SAR and Kinetic Studies on ω-[N-Methyl-N-(3-alkylcarbamoyloxyphenyl)methyl]aminoalkoxyaryl Derivatives
- 13 October 2001
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 44 (23) , 3810-3820
Abstract
In this work, we further investigated a class of carbamic cholinesterase inhibitors introduced in a previous paper (Rampa et al. J. Med. Chem. 1998, 41, 3976). Some new ω-[N-methyl-N-(3-alkylcarbamoyloxyphenyl)methyl]aminoalkoxyaryl analogues were designed, synthesized, and evaluated for their inhibitory activity against both acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE). The structure of the lead compound (xanthostigmine) was systematically varied with the aim to optimize the different parts of the molecule. Moreover, such a structure−activity relationships (SAR) study was integrated with a kinetic analysis of the mechanism of AChE inhibition for two representative compounds. The structural modifications lead to a compound (12b) showing an IC50 value for the AChE inhibition of 0.32 ± 0.09 nM and to a group of BuChE inhibitors also active at the nanomolar level, the most potent of which (15d) was characterized by an IC50 value of 3.3 ± 0.4 nM. The kinetic analysis allowed for clarification of the role played by different molecular moieties with regard to the rate of AChE carbamoylation and the duration of inhibition. On the basis of the results presented here, it was concluded that the cholinesterase inhibitors of this class possess promising characteristics in view of a potential development as drugs for the treatment of Alzheimer's disease.Keywords
This publication has 14 references indexed in Scilit:
- “Back Door” Opening Implied by the Crystal Structure of a Carbamoylated AcetylcholinesteraseBiochemistry, 1999
- Cholinergic therapies in Alzheimer's diseaseDrugs of the Future, 1999
- Acetylcholinesterase Inhibitors: Synthesis and Structure−Activity Relationships of ω-[N-Methyl-N-(3-alkylcarbamoyloxyphenyl)- methyl]aminoalkoxyheteroaryl DerivativesJournal of Medicinal Chemistry, 1998
- Acetylcholinesterase Accelerates Assembly of Amyloid-β-Peptides into Alzheimer's Fibrils: Possible Role of the Peripheral Site of the EnzymeNeuron, 1996
- Synthesis and structure-activity relationships of new acetylcholinesterase inhibitors: Morpholinoalkylcarbamoyloxyeseroline derivativesBioorganic & Medicinal Chemistry Letters, 1995
- Phenserine and ring C hetero‐analogues: Drug candidates for the treatment of Alzheimer's diseaseMedicinal Research Reviews, 1995
- Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase.Proceedings of the National Academy of Sciences, 1993
- The Cholinergic Hypothesis of Geriatric Memory DysfunctionScience, 1982
- Pituitary Tumors in Mice after Prolonged Feeding of Synthetic ProgestinsScience, 1966
- A new and rapid colorimetric determination of acetylcholinesterase activityBiochemical Pharmacology, 1961